XLV, the Health Care Select Sector SPDR ETF, is flashing an unusual divergence this week: the fund touched a 52-week high just days ago, yet short sellers are piling in at the fastest pace in months and options traders are loading up on downside protection at near-extreme levels.
The most striking signal right now is in options. The put/call ratio has climbed to 1.56 — almost three standard deviations above its 20-day mean of 1.46. That z-score of 2.89 is the most defensive positioning reading seen on XLV in months. The ratio has been creeping higher all month, but the move this week is sharp enough to stand out even within a fund that structurally carries more puts than calls. Traders are paying meaningfully more to hedge healthcare exposure here than they have in some time.
Short interest tells a consistent story. Bears have added roughly 24% more short exposure over the past week alone, pushing XLV's short interest to 7.1% of free float — up from around 5.9% a month ago. In raw share terms, borrowed positions jumped from roughly 14.8 million to 18.4 million between September 8 and September 15, a build that accelerated sharply after September 8. The pace is notable for an ETF: this is not sector-rotation noise, it is a deliberate directional bet against healthcare. The cost to borrow remains low at 0.72%, so there is no friction discouraging new shorts from entering — building a position here is still cheap.
Borrow availability, however, has tightened considerably and is now the most important cross-check on how far this short build can go. Availability fell nearly 29% on the week to around 103% of short interest — meaning the pool of lendable shares has shrunk to roughly one share available for every share already borrowed. That compares to availability ratios of 170–360% just two to four weeks ago when the borrow market was loose. The 52-week tightest point on record for XLV is a 24% availability ratio, so the market is not yet close to that extreme, but the direction of travel is fast. If short sellers keep adding at this week's pace, availability could tighten further into genuinely constrained territory.
The setup carries an interesting internal tension. XLV itself is up 0.3% on the week and only a hair below its recent 52-week high, with a solid 0.17% gain on the month. The ORTEX short score has edged up to 57.9 this week from 52.5 two weeks ago — elevated but not extreme. The fund's largest institutional holders, led by Managed Account Advisors with over 9% of shares and Morgan Stanley and JPMorgan in the next tier, have not shown dramatic recent exits based on June quarter-end filings. Goldman Sachs actually added nearly 1.3 million shares as of that same reporting date. The ETF structure means there is a natural ceiling on how extreme short interest can get — authorised participants can create new shares to meet redemptions — but the pace of the current build still warrants attention.
What to watch next is whether the put/call ratio sustains above 1.55 into next week, and whether availability continues compressing toward the tighter end of its historical range — those two together would suggest the bearish positioning is becoming structural rather than a short-term tactical hedge.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
